Breaking News Instant updates and real-time market news.

BOLD

Audentes Therapeutics

$35.22

-2.76 (-7.27%)

13:08
08/07/18
08/07
13:08
08/07/18
13:08

Audentes update on AT132 should put concerns to rest, says Piper Jaffray

Piper Jaffray analyst Christopher Raymond says Audentes Therapeutics provided an "incrementally positive" clinical update for lead asset AT132 when reporting Q2 results this morning. With all patients now experiencing "meaningful" reductions of ventilator time and "now impressive" muscle biopsy data, questions around this drug's clinical activity and therapeutic window "should be put to rest," Raymond tells investors in a research note. The analyst believes the only question that remains is around optimal dose. He continues to recommend purchase of Audentes Therapeutics with an Overweight rating adn $45 price target.

  • 07

    Aug

  • 07

    Aug

  • 14

    Aug

BOLD Audentes Therapeutics
$35.22

-2.76 (-7.27%)

05/17/18
HCWC
05/17/18
NO CHANGE
Target $40
HCWC
Buy
Audentes Therapeutics price target raised to $40 from $37 at H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay raised his price target for Audentes Therapeutics to $40 after the company presented updated data from its most advanced gene therapy AT132, for the treatment of X-linked myotubular myopathy. The analyst says that while he would have preferred a cleaner read from the ventilator support endpoint, the follow up periods could be inadequate. He expects to see continued improvements at month 12 versus the current follow up periods. Chattopadhyay views the AT132 data as encouraging and keeps a Buy rating on Audentes.
05/17/18
LEER
05/17/18
NO CHANGE
Target $43
LEER
Outperform
Audentes' updated data from ASPIRO study 'very impressive,' says Leerink
Leerink analyst Joseph Schwartz said Audentes Therapeutics presented a "very impressive" update to its Phase 1/2 ASPIRO study and he believes heavily scrutinizing AT132's safety profile "may miss the bigger picture" at this point, as he contends the numbers appear skewed by select patients. He remains optimistic on the prospects for AT132 in X-linked myotubular myopathy and reiterates an Outperform rating and $43 price target on Audentes shares.
05/21/18
MZHO
05/21/18
NO CHANGE
Target $38
MZHO
Neutral
Audentes Therapeutics price target raised to $38 from $26 at Mizuho
Mizuho analyst Difei Yang raised his price target for Audentes Therapeutics to $38 saying she's "very encouraged" by the updated data from AT-132, which showed continued improvements in the first cohort of patients, as well as early positive data in the expansion cohort. The analyst now sees a "stronger probability of success" for the AT-132 program. She keeps a Neutral rating on Audentes Therapeutics shares due to valuation.
06/25/18
CHDN
06/25/18
INITIATION
Target $36
CHDN
Neutral
Audentes Therapeutics initiated with a Neutral at Chardan
Chardan analyst Gbola Amusa initiated Audentes Therapeutics with a Neutral and $35 price target.

TODAY'S FREE FLY STORIES

06:45
11/21/18
11/21
06:45
11/21/18
06:45
General news
Breaking General news story  »

Week of 11/16 MBA…

GPS

Gap

$24.65

-0.79 (-3.11%)

06:43
11/21/18
11/21
06:43
11/21/18
06:43
Periodicals
Gap reviews whether to close hundreds of weaker locations, WSJ reports »

Gap is evaluating whether…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

ECOM

ChannelAdvisor

$10.44

-0.12 (-1.14%)

06:42
11/21/18
11/21
06:42
11/21/18
06:42
Conference/Events
ChannelAdvisor management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 11

    Dec

TCEHY

Tencent

$0.00

(0.00%)

, SPOT

Spotify

$129.73

2.99 (2.36%)

06:37
11/21/18
11/21
06:37
11/21/18
06:37
Periodicals
Tencent Music Entertainment could push IPO until 2019, Reuters reports »

Tencent Music…

TCEHY

Tencent

$0.00

(0.00%)

SPOT

Spotify

$129.73

2.99 (2.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$91.76

-0.33 (-0.36%)

06:36
11/21/18
11/21
06:36
11/21/18
06:36
Periodicals
United wins victory in Newark Airport fee dispute, WSJ reports »

The Federal Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

BGNE

BeiGene

$125.87

1.5 (1.21%)

06:36
11/21/18
11/21
06:36
11/21/18
06:36
Initiation
BeiGene initiated  »

BeiGene initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

  • 03

    Dec

NMHLY

NMC Health

$0.00

(0.00%)

06:34
11/21/18
11/21
06:34
11/21/18
06:34
Upgrade
NMC Health rating change  »

NMC Health upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADI

Analog Devices

$89.12

3.57 (4.17%)

06:33
11/21/18
11/21
06:33
11/21/18
06:33
Recommendations
Analog Devices analyst commentary  »

Analog Devices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

AAPL

Apple

$177.10

-8.7 (-4.68%)

06:32
11/21/18
11/21
06:32
11/21/18
06:32
Periodicals
Apple in talks to provide veterans access to electronic health records, WSJ says »

Apple is in talks with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

SWGAY

Swatch Group

$0.00

(0.00%)

06:31
11/21/18
11/21
06:31
11/21/18
06:31
Downgrade
Swatch Group rating change  »

Swatch Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWGAY

Swatch Group

$0.00

(0.00%)

06:31
11/21/18
11/21
06:31
11/21/18
06:31
Downgrade
Swatch Group rating change  »

Swatch Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXCM

DexCom

$119.89

-1.34 (-1.11%)

, GOOG

Alphabet

$1,026.00

7 (0.69%)

06:28
11/21/18
11/21
06:28
11/21/18
06:28
Recommendations
DexCom, Alphabet, Alphabet Class A analyst commentary  »

Amended Verily agreement…

DXCM

DexCom

$119.89

-1.34 (-1.11%)

GOOG

Alphabet

$1,026.00

7 (0.69%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

JD

JD.com

$19.49

-1.6 (-7.59%)

06:26
11/21/18
11/21
06:26
11/21/18
06:26
Periodicals
JD.com 'Singles Day' fueled by illegal student labor, FT reports »

Over 100,000 employees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$63.54

1.35 (2.17%)

06:26
11/21/18
11/21
06:26
11/21/18
06:26
Upgrade
Best Buy rating change  »

Best Buy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

DE

Deere

$138.49

-4.04 (-2.83%)

06:21
11/21/18
11/21
06:21
11/21/18
06:21
Hot Stocks
Breaking Hot Stocks news story on Deere »

Deere down 4.7% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

LOW

Lowe's

$86.15

-5.19 (-5.68%)

, HD

Home Depot

$169.17

-4.45 (-2.56%)

06:21
11/21/18
11/21
06:21
11/21/18
06:21
Downgrade
Lowe's, Home Depot rating change  »

Lowe's downgraded to…

LOW

Lowe's

$86.15

-5.19 (-5.68%)

HD

Home Depot

$169.17

-4.45 (-2.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BJ

BJ's Wholesale

$19.85

-0.22 (-1.10%)

06:21
11/21/18
11/21
06:21
11/21/18
06:21
Recommendations
BJ's Wholesale analyst commentary  »

BJ's Wholesale is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNSKY

Danske Bank

$0.00

(0.00%)

06:21
11/21/18
11/21
06:21
11/21/18
06:21
Periodicals
Danske Bank faces money laundering lawsuit, FT reports »

Danske Bank is facing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCO

Columbus McKinnon

$34.04

-0.56 (-1.62%)

06:21
11/21/18
11/21
06:21
11/21/18
06:21
Conference/Events
Columbus McKinnon management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

DFS

Discover

$68.27

-1.315 (-1.89%)

06:19
11/21/18
11/21
06:19
11/21/18
06:19
Hot Stocks
Discover's Diners partners with Brazil's Elo to launch Elo Diners Club cards »

Discover's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMES

Emerge Energy

$2.73

0.03 (1.11%)

06:17
11/21/18
11/21
06:17
11/21/18
06:17
Recommendations
Emerge Energy analyst commentary  »

Emerge Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$138.49

-4.04 (-2.83%)

06:17
11/21/18
11/21
06:17
11/21/18
06:17
Hot Stocks
Deere CEO says company has 'continued to face cost pressures for raw materials' »

"John Deere has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

CLGX

CoreLogic

$39.31

-0.32 (-0.81%)

06:16
11/21/18
11/21
06:16
11/21/18
06:16
Conference/Events
CoreLogic management to meet with SunTrust »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

DE

Deere

$138.49

-4.04 (-2.83%)

06:15
11/21/18
11/21
06:15
11/21/18
06:15
Hot Stocks
Deere sees FY19 CapEx approximately $1.15B 

Up from $893M in FY18.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

DE

Deere

$138.49

-4.04 (-2.83%)

06:14
11/21/18
11/21
06:14
11/21/18
06:14
Earnings
Deere sees FY19 net income approximately $3.6B »

FY19 EPS consensus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.